Shopping Cart
- Remove All
- Your shopping cart is currently empty
(1R,2R)-ML-SI3 ((-)-trans-ML-SI3) is a selective TRPML1, TRPML2, and TRPML3 inhibitor for the study of neurodegenerative and cardiovascular diseases.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $233 | In Stock | |
25 mg | $1,110 | 6-8 weeks | |
50 mg | $1,450 | 6-8 weeks | |
100 mg | $2,320 | 6-8 weeks |
Description | (1R,2R)-ML-SI3 ((-)-trans-ML-SI3) is a selective TRPML1, TRPML2, and TRPML3 inhibitor for the study of neurodegenerative and cardiovascular diseases. |
Targets&IC50 | TRPML3:12.5 μM, TRPML2:2.3 μM, TRPML1:1.6 μM |
In vitro | (1R,2R)-ML-SI3 is an isomer of ML-SI3 and a potent inhibitor of all three TRPML isoforms. (1R,2R)-ML-SI3 was a potent inhibitor of TRPML1 (IC50=1.6 μM), TRPML2 (IC50=2.3 μM) and TRPML3 (IC50=12.5 μM), (1R,2R)-ML-SI3 was a potent inhibitor of TRPML1 and TRPML2 and a weak inhibitor of TRPML3. [1] |
Alias | (-)-trans-ML-SI3 |
Molecular Weight | 429.58 |
Formula | C23H31N3O3S |
Cas No. | 2418594-00-8 |
Smiles | N(S(=O)(=O)C1=CC=CC=C1)[C@H]2[C@@H](CCCC2)N3CCN(CC3)C4=C(OC)C=CC=C4 |
Storage | keep away from direct sunlight,store at low temperature | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL(186.23 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.